Dr. Usman  Sumo Friend Tambunan

Dr. Usman Sumo Friend Tambunan

Professor
University of Indonesia, Indonesia


Highest Degree
PostDoc Fellow in Pharmaceutical Chemistry from Kansas State University, Manhattan, Kansas, USA

Share this Profile

Biography

done

Area of Interest:

Pharmacology and Toxicology
100%
Biochemistry
62%
Pharmacology
90%
Molecular Biology
75%
Biotechnology
55%

Education

1992

PostDoc Fellow

Kansas State University, Manhattan, Kansas, USA

Pharmaceutical Chemistry

Selected Publications

  1. Tambunan, U.S.F., M.A.F. Nasution, F. Azhima, A.A. Parikesit, E.P. Toepak, S. Idrus and D. Kerami, 2017. Modification of S-Adenosyl-L-Homocysteine as inhibitor of nonstructural protein 5 methyltransferase dengue virus through molecular docking and molecular dynamics simulation. Drug Target Insights, Vol. 11. 10.1177/1177392817701726.
    CrossRef  |  

  2. Tambunan, U.S.F., A.H. Alkaff, M.A.F. Nasution, A.A. Parikesit and D. Kerami, 2017. Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain ebola virus through in silico analysis. J. Mol. Graphics Modell., 74: 366-378.
    CrossRef  |  

  3. Tambunan, U.S.F., A.A. Parikesit, V.C. Adam, M.A.F. Nasution, R.D. Puspitasari and D. Kerami, 2017. Virtual screening of commercial cyclic peptides as β-OG pocket binder inhibitor in dengue virus serotype 2. Int. J. GEOMATE, 12: 60-68.
    CrossRef  |  

  4. Tambunan, U.S.F., A.A. Parikesit, M.A.F. Nasution, A. Hapsari and D. Kerami, 2017. Exposing the molecular screening method of indonesian natural products derivate as drug candidates for cervical cancer. Iran. J. Pharm. Res., 16: 1113-1127.
    Direct Link  |  

  5. Tambunan, U.S.F., A.A. Parikesit, F. Wardani and M.A.F. Nasution, 2017. In silico study of guanosine triphosphate (GTP) and ribavirin derivatives as the inhibitor for NS5 methyltransferase of dengue virus. Rasayan J. Chem., 10: 910-921.
    CrossRef  |  

  6. Zahroh, H., A. Ma’rup, U.S.F. Tambunan and A.A. Parikesit, 2016. Immunoinformatics approach in designing epitope-based vaccine against meningitis-inducing bacteria (streptococcus pneumoniae, neisseria meningitidis, and haemophilus influenzae type b). Drug Target Insights, 10: 19-29.
    CrossRef  |  

  7. Tambunan, U.S.F., W. Chua, A.A. Parikesit and D. Kerami, 2016. Designing disulfide cyclic peptide as fusion inhibitor that targets denv envelope protein. Jurnal Teknologi, 78: 95-103.
    CrossRef  |  Direct Link  |  

  8. Tambunan, U.S.F., M.A.F. Nasution, A.A. Parikesit, H. Noviardi and D. Kerami, 2016. Designing of disulfide cyclic peptide for inhibiting polymerase A and B1 (PAC-PB1N) in H1N1 virus using molecular simulation approach. OnLine J. Biol. Sci., 16: 122-129.
    CrossRef  |  

  9. Tambunan, U.S.F., F.R.P. Sipahutar, A.A. Parikesit and D. Kerami, 2016. Vaccine design for H5N1 based on B- and T-cell epitope predictions. Bioinf. Biol. Insights, 10: 27-35.
    CrossRef  |  

  10. Tambunan, U.S.F., R.A. Rachmania and A.A. Parikesit, 2015. In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1. J. Biomed. Res., 29: 150-159.
    Direct Link  |  

  11. Tambunan, U.S.F., A.A. Parikesit, Y.C. Unadi and D. Kerami, 2015. Designing cyclopentapeptide inhibitor of neuraminidase H5N1 virus through molecular and pharmacology simulations. Tsinghua Sci. Technol., 20: 431-440.
    CrossRef  |  Direct Link  |  

  12. Tambunan, U.S., H. Zahroh, A.A. Parikesit, S. Idrus and D. Kerami, 2015. Screening analogs of β-OG pocket binder as fusion inhibitor of dengue virus 2. Drug Target Insights, 9: 33-49.
    CrossRef  |  

  13. Tambunan, U.S., A.A. Parikesit, A.S. Ghifari and C.P. Satriyanto, 2015. In silico identification of 2-oxo-1, 3-thiazolidine derivatives as novel inhibitor candidate of class II histone deacetylase (HDAC) in cervical cancer treatment. Arabian J. Chem. 10.1016/j.arabjc.2015.07.010.
    CrossRef  |  

  14. Prasasty, V.D., M.E. Krause, U.S. Tambunan, A. Anbanandam, J.S. Laurence and T.J. Siahaan, 2015. 1H, 13C and 15N backbone assignment of the EC-1 domain of human E-cadherin. Biomolecular NMR Assignments, 9: 31-35.
    CrossRef  |  Direct Link  |  

  15. Tambunan, U.S.F., H. Zahroh, B.B. Utomo and A.A. Parikesit, 2014. Screening of commercial cyclic peptide as inhibitor NS5 methyltransferase of dengue virus through molecular docking and molecular dynamics simulation. Bioinformation, 10: 23-27.
    Direct Link  |  

  16. Tambunan, U.S.F., A.A. Parikesit and F.R.P. Sipahutar, 2014. Computational design of drug candidates for influenza a virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme. Acta Pharm., 64: 157-172.
    CrossRef  |  Direct Link  |  

  17. Tambunan, U.S.F., A. Randy and A.A. Parikesit, 2014. Design of Candida antarctica lipase B thermostability improvement by introducing extra disulfide bond into the enzyme. Online J. Biol. Sci., 14: 108-118.
    CrossRef  |  Direct Link  |  

  18. Prasasty, V.D., U.S.F. Tambunan and T.J. Siahaan, 2014. Homology modeling and molecular dynamics studies of EC1 domain of VE-cadherin to elucidate docking interaction with cadherin-derived peptide. OnLine J. Biol. Sci., 14: 155-162.
    Direct Link  |  

  19. Bakri, R., A.A. Parikesit, C.P. Satriyanto, D. Kerami and U.S.F. Tambunan, 2014. Utilization of boron compounds for the modification of suberoyl anilide hydroxamic acid as inhibitor of histone deacetylase class II Homo sapiens. Adv. Bioinformatics, Vol. 2014. 10.1155/2014/104823.
    CrossRef  |  

  20. Tambunan, U.S.F., R. Bakri, T. Prasetia, A.A. Parikesit and D. Kerami, 2013. Molecular dynamics simulation of complex histones deacetylase (HDAC) class II homo sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer. Bioinf., 9: 696-700.
    CrossRef  |  Direct Link  |  

  21. Tambunan, U.S.F., M.R. Rahdiansyah and A.A. Parikesit, 2013. In silico design of the M2 proton channel inhibitors of H1N1 virus. OnLine J. Biol. Sci., 13: 1-12.

  22. Parikesit, A.A., Kinanty and U.S.F. Tambunan, 2013. Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics. Pak. J. Biol. Sci., 16: 1836-1848.
    CrossRef  |  PubMed  |  Direct Link  |  

  23. Tambunan, U.S.F., N. Amri and A.A. Parikesit, 2012. In silico design of cyclic peptides as influenza virus, a subtype H1N1 neuraminidase inhibitor. Afr. J. Biotechnol., 11: 11474-11491.
    CrossRef  |  Direct Link  |  

  24. Tambunan, U.S.F., D. Febrianto and A.A. Parikesit, 2012. In silico genetic variation pathogenicity analysis of hemagglutinin, matrix 1 and non structural 1 protein of human H5N1 Indonesian strain. IIOABJ., 3: 5-14.
    Direct Link  |  

  25. Idrus, S. and U.S. Tambunan, 2012. Simulation of riboflavin synthase in Eremothecium gossypii conversion of 6, 7-dimethyl-8-ribityllumazine to riboflavin. Online J. Bioinformat., 13: 41-49.

  26. Tambunan, U.S.F., N. Apriyanti, A.A. Parikesit, W. Chua and K. Wuryani, 2011. Computational design of disulfide cyclic peptide as potential inhibitor of complex NS2B-NS3 dengue virus protease. Afr. J. Biotechnol., 10: 12281-12290.
    Direct Link  |  

  27. Tambunan, U.S.F., N Bramantya and A.A. Parikesit, 2011. In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC). BMC Bioinformatics, Vol. 12, 10.1186/1471-2105-12-S13-S23.
    CrossRef  |  PubMed  |  Direct Link  |  

  28. Tambunan, U.S.F., S. Sugito and A.A. Parikesit, 2010. Design and evaluation of three pair primers for exon 1 amplification of hyaluroglucosaminidase-1 gene. OnLine J. Biol. Sci., 10: 66-72.
    Direct Link  |